Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding

被引：23
作者：
Epperla, Narendranath [1 ]
Kapke, Jonathan T. [2 ]
Karafin, Matthew [3 ]
Friedman, Kenneth D. [1 ]
Foy, Patrick [1 ]
机构：
[1] Med Coll Wisconsin, Div Hematol & Oncol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Div Transfus Med, Milwaukee, WI 53226 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 06期
关键词：
MALFORMATIONS; MANAGEMENT;
D O I：
10.1002/ajh.24367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E313 / E314
页数：3
相关论文
共 50 条
  • [1] Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia
    Kanellopoulou, Theoni
    Alexopoulou, Alexandra
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1315 - 1323
  • [2] Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia
    Khoueir, Nadim
    Borsik, Michel
    Camous, Domitille
    Herman, Philippe
    Verillaud, Benjamin
    LARYNGOSCOPE, 2019, 129 (10) : 2210 - 2215
  • [3] How I treat bleeding in hereditary hemorrhagic telangiectasia
    Al-Samkari, Hanny
    BLOOD, 2024, 144 (09) : 940 - 954
  • [4] Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
    Faughnan, Marie E.
    Gossage, James R.
    Chakinala, Murali M.
    Oh, S. Paul
    Kasthuri, Raj
    Hughes, Christopher C. W.
    McWilliams, Justin P.
    Parambil, Joseph G.
    Vozoris, Nicholas
    Donaldson, Jill
    Paul, Gitanjali
    Berry, Pamela
    Sprecher, Dennis L.
    ANGIOGENESIS, 2019, 22 (01) : 145 - 155
  • [5] Hereditary hemorrhagic telangiectasia
    Grand'Maison, Anne
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (08) : 833 - 835
  • [6] Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?
    Epperla, Narendranath
    Kleman, Ariel
    Karafin, Matthew
    Foy, Patrick
    ANNALS OF HEMATOLOGY, 2018, 97 (09) : 1727 - 1729
  • [7] Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis
    Braak, S. J.
    de Witt, C. A.
    Disch, F. J. M.
    Overtoom, T. Th. C.
    Westermann, J. J.
    RHINOLOGY, 2009, 47 (02) : 166 - 171
  • [8] Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose
    Dheyauldeen, Sinan
    Geirdal, Amy Ostertun
    Osnes, Terje
    Vartdal, Liv Sofie
    Dollner, Ralph
    LARYNGOSCOPE, 2012, 122 (06) : 1210 - 1214
  • [9] Schizencephaly in Hereditary Hemorrhagic Telangiectasia
    Gaines, J. J.
    Gilbert, B. C.
    Gossage, J. R.
    Parker, W.
    Reddy, A.
    Forseen, S. E.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2022, 43 (11) : 1603 - 1607
  • [10] The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia
    Richer, Sara L.
    Geisthoff, Urban W.
    Livada, Nancy
    Ward, P. Daniel
    Johnson, Leland
    Mainka, Alexander
    Henderson, Katharine J.
    Maune, Steffen
    White, Robert I., Jr.
    Ross, Douglas A.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2012, 26 (05) : 401 - 404
12345